Does EVOLOCUMAB Cause Device defective? 363 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 363 reports of Device defective have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.
363
Reports of Device defective with EVOLOCUMAB
0.2%
of all EVOLOCUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Device defective From EVOLOCUMAB?
Of the 363 reports, 6 (1.7%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Device defective Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 363 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Device defective?
SOMATROPIN (1,719)
USTEKINUMAB (1,071)
SECUKINUMAB (666)
GUSELKUMAB (574)
GOLIMUMAB (539)
ABATACEPT (458)
ALBUTEROL (445)
TOCILIZUMAB (400)
INSULIN GLARGINE (397)
EXENATIDE (387)
Which EVOLOCUMAB Alternatives Have Lower Device defective Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE